Error! You must javascript enabled to use this form. Please enable Javascript in your browser. NASDAQ: PGNX Investor Notice: Investigation of Takeover of Progenics Pharmaceuticals, Inc. An investigation was announced concerning whether the takeover of Progenics Pharmaceuticals, Inc. is unfair NASDAQ: PGNX stockholders. View full press release Your Name: Your Email: Subject: Question: ReleaseWire respects your privacy, the information you entered above will not be used to send unsolicited email, and will not be rented or sold to a 3rd party. Your contact information will be shared with the recipient of this message - Privacy Policy Send